Marcia Brose, University of Pennsylvania School of Medicine (IMAGE)

University of Pennsylvania School of Medicine

Marcia Brose, University of Pennsylvania School of Medicine

Caption

Marcia Brose, M.D., Ph.D., lead investigator of the DECISION trial of sorafenib for patients with metastatic thyroid cancer. The findings of the trial are to be presented at the American Society of Clinical Oncology's Annual Meeting on Sunday, June 2, 2013.

Credit

Penn Medicine

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.